168 related articles for article (PubMed ID: 33933118)
1. Quality assurance of radiotherapy in the ongoing EORTC 1420 "Best of" trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure.
Stelmes JJ; Vu E; Grégoire V; Simon C; Clementel E; Kazmierska J; Grant W; Ozsahin M; Tomsej M; Vieillevigne L; Fortpied C; Hurkmans EC; Branquinho A; Andratschke N; Zimmermann F; Weber DC
Radiat Oncol; 2021 May; 16(1):81. PubMed ID: 33933118
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
Christiaens M; Collette S; Overgaard J; Gregoire V; Kazmierska J; Castadot P; Giralt J; Grant W; Tomsej M; Bar-Deroma R; Monti AF; Hurkmans CW; Weber DC
Radiother Oncol; 2017 Jun; 123(3):424-430. PubMed ID: 28478912
[TBL] [Abstract][Full Text] [Related]
3. Interobserver variability in organ at risk delineation in head and neck cancer.
van der Veen J; Gulyban A; Willems S; Maes F; Nuyts S
Radiat Oncol; 2021 Jun; 16(1):120. PubMed ID: 34183040
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results.
Lambrecht M; Clementel E; Sonke JJ; Nestle U; Adebahr S; Guckenberger M; Andratschke N; Weber DC; Verheij M; Hurkmans CW
Radiother Oncol; 2019 Mar; 132():63-69. PubMed ID: 30825971
[TBL] [Abstract][Full Text] [Related]
5. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
[TBL] [Abstract][Full Text] [Related]
6. Geometric and dosimetric evaluations of atlas-based segmentation methods of MR images in the head and neck region.
Kieselmann JP; Kamerling CP; Burgos N; Menten MJ; Fuller CD; Nill S; Cardoso MJ; Oelfke U
Phys Med Biol; 2018 Jul; 63(14):145007. PubMed ID: 29882749
[TBL] [Abstract][Full Text] [Related]
7. Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer.
Nelms BE; Tomé WA; Robinson G; Wheeler J
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):368-78. PubMed ID: 21123004
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case.
Song YC; Hu ZH; Yan XN; Fang H; Tang Y; Jing H; Men K; Zhang N; Zhang J; Jin J; Zhong QZ; Ma J; Yang WF; Zhong YH; Dong LH; Wang XH; Wu HF; Du XH; Hou XR; Tie J; Lu YF; Zhao LN; Li YX; Wang SL
Radiat Oncol; 2023 Nov; 18(1):194. PubMed ID: 38031125
[TBL] [Abstract][Full Text] [Related]
9. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis.
Fairchild A; Langendijk JA; Nuyts S; Scrase C; Tomsej M; Schuring D; Gulyban A; Ghosh S; Weber DC; Budach W
Radiat Oncol; 2014 Nov; 9():248. PubMed ID: 25424399
[TBL] [Abstract][Full Text] [Related]
12. Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans-Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise.
Cloak K; Jameson MG; Paneghel A; Wiltshire K; Kneebone A; Pearse M; Sidhom M; Tang C; Fraser-Browne C; Holloway LC; Haworth A
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):390-398. PubMed ID: 30950223
[TBL] [Abstract][Full Text] [Related]
13. RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.
Doornaert P; Verbakel WF; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):429-35. PubMed ID: 20421159
[TBL] [Abstract][Full Text] [Related]
14. Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.
Verbakel WFAR; Doornaert PAH; Raaijmakers CPJ; Bos LJ; Essers M; van de Kamer JB; Dahele M; Terhaard CHJ; Kaanders JHAM
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):514-524. PubMed ID: 31306734
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging organ at risk delineation for nasopharyngeal radiotherapy: Measuring the effectiveness of an educational intervention.
Ryan O; Dundas K; Surjan Y; Elwadia D; Nguyen K; Cardoso M; Kumar S
J Med Radiat Sci; 2023 Apr; 70 Suppl 2(Suppl 2):59-69. PubMed ID: 36751021
[TBL] [Abstract][Full Text] [Related]
16. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
[TBL] [Abstract][Full Text] [Related]
17. Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
Okamoto H; Murakami N; Isohashi F; Kasamatsu T; Hasumi Y; Iijima K; Nishioka S; Nakamura S; Nakamura M; Nishio T; Igaki H; Nakayama Y; Itami J; Ishikura S; Nishimura Y; Toita T
Radiat Oncol; 2019 Jul; 14(1):133. PubMed ID: 31358026
[TBL] [Abstract][Full Text] [Related]
18. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
19. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
[TBL] [Abstract][Full Text] [Related]
20. The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results.
Habraken SJM; Sharfo AWM; Buijsen J; Verbakel WFAR; Haasbeek CJA; Öllers MC; Westerveld H; van Wieringen N; Reerink O; Seravalli E; Braam PM; Wendling M; Lacornerie T; Mirabel X; Weytjens R; Depuydt L; Tanadini-Lang S; Riesterer O; Haustermans K; Depuydt T; Dwarkasing RS; Willemssen FEJA; Heijmen BJM; Méndez Romero A
Radiother Oncol; 2017 Dec; 125(3):507-513. PubMed ID: 29050954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
